Brain Dynamics and Temporal Summation of Pain Predicts Neuropathic Pain Relief from Ketamine Infusion

被引:80
|
作者
Bosma, Rachael L. [1 ]
Cheng, Joshua C. [1 ,3 ]
Rogachov, Anton [1 ,3 ]
Kim, Junseok A. [1 ,3 ]
Hemington, Kasey S. [1 ,3 ]
Osborne, Natalie R. [1 ,3 ]
Raghavan, Lakshmikumar Venkat [2 ,4 ]
Bhatia, Anuj [1 ,2 ,4 ,5 ]
Davis, Karen D. [1 ,3 ,6 ]
机构
[1] Univ Hlth Network, Toronto Western Hosp, Div Brain Imaging & Behav Syst Neurosci, Krembil Brain Inst,Krembil Res Inst, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto Western Hosp, Dept Anesthesia & Pain Management, Toronto, ON, Canada
[3] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[4] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[6] Univ Toronto, Dept Surg, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
RECEPTOR ANTAGONIST DEXTROMETHORPHAN; 2ND PAIN; FUNCTIONAL CONNECTIVITY; CENTRAL SENSITIZATION; FIBROMYALGIA PATIENTS; MECHANISMS; MAINTENANCE; VALIDATION; INVENTORY; NETWORKS;
D O I
10.1097/ALN.0000000000002417
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Ketamine is an N-methyl-d-aspartate receptor antagonist that reduces temporal summation of pain and modulates antinociception. Ketamine infusions can produce significant relief of neuropathic pain, but the treatment is resource intensive and can be associated with adverse effects. Thus, it is crucial to select patients who might benefit from this treatment. The authors tested the hypothesis that patients with enhanced temporal summation of pain and the capacity to modulate pain via the descending antinociceptive brain pathway are predisposed to obtain pain relief from ketamine. Methods: Patients with refractory neuropathic pain (n = 30) and healthy controls underwent quantitative sensory testing and resting-state functional magnetic resonance imaging and then completed validated questionnaires. Patients then received outpatient intravenous ketamine (0.5 to 2mg . kg(-1). h(-1); mean dose 1.1 mg .kg(-1) . h(-1)) for 6h/day for 5 consecutive days. Pain was assessed 1 month later. Treatment response was defined as greater than or equal to 30% pain relief (i.e., reduction in pain scores). We determined the relationship between our primary outcome measure of pain relief with pretreatment temporal summation of pain and with brain imaging measures of dynamic functional connectivity between the default mode network and the descending antinociceptive brain pathway. Results: Approximately 50% of patients achieved pain relief (mean SD; Responders, 61 +/- 35%; Nonresponders, 7 +/- 14%). Pretreatment temporal summation was associated with the effect of ketamine (rho = -0.52, P = 0.003) and was significantly higher in Responders (median [25th, 75th] = 200 [100, 345]) compared with Nonresponders (44 [9, 92]; P = 0.001). Pretreatment dynamic connectivity was also associated with the clinical effect of ketamine (rho = 0.51, P = 0.004) and was significantly higher in Responders (mean +/- SD, 0.55 +/- 0.05) compared with Nonresponders (0.51 +/- 0.03; P = 0.006). Finally, the dynamic engagement of the descending antinociceptive system significantly mediated the relationship between pretreatment pain facilitation and pain relief (95% CI, 0.005 to 0.065). Conclusions: These findings suggest that brain and behavioral measures have the potential to prognosticate and develop ketamine-based personalized pain therapy.
引用
收藏
页码:1015 / 1024
页数:10
相关论文
共 50 条
  • [31] KETAMINE INFUSION FOR NEUROPATHIC PAIN IN CHILDREN WITH CANCER: KING HUSSEIN CANCER CENTER EXPERIENCE
    Al-Nassan, Anwar
    Al-Awadi, Shireen
    Sultan, Iyad
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S332 - S333
  • [32] Outpatient Treatment with Ultra Low Dose Ketamine Infusion for Neuropathic pain in patients with Neurofibromatosis
    Acosta, M.
    Shibuya, P.
    Brown, M.
    Lee, J.
    Alexander, S.
    ANNALS OF NEUROLOGY, 2016, 80 : S414 - S414
  • [33] Temporal summation of mechanical pain prospectively predicts movement-evoked pain severity in adults with chronic low back pain
    Overstreet, Demario S.
    Michl, Ava N.
    Penn, Terence M.
    Rumble, Deanna D.
    Aroke, Edwin N.
    Sims, Andrew M.
    King, Annabel L.
    Hasan, Fariha N.
    Quinn, Tammie L.
    Long, D. Leann
    Sorge, Robert E.
    Goodin, Burel R.
    BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [34] Temporal summation of mechanical pain prospectively predicts movement-evoked pain severity in adults with chronic low back pain
    Demario S. Overstreet
    Ava N. Michl
    Terence M. Penn
    Deanna D. Rumble
    Edwin N. Aroke
    Andrew M. Sims
    Annabel L. King
    Fariha N. Hasan
    Tammie L. Quinn
    D. Leann Long
    Robert E. Sorge
    Burel R. Goodin
    BMC Musculoskeletal Disorders, 22
  • [35] Dynamic, but not static, pain sensitivity predicts exercise-induced muscle pain: Covariation of temporal sensory summation and pain intensity
    Bishop, Mark D.
    George, Steven Z.
    Robinson, Michael E.
    NEUROSCIENCE LETTERS, 2012, 526 (01) : 1 - 4
  • [36] Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain
    ArendtNielsen, L
    Nielsen, J
    PetersenFelix, S
    Schnider, TW
    Zbinden, AM
    BRITISH JOURNAL OF ANAESTHESIA, 1996, 77 (05) : 625 - 631
  • [37] Infusion Therapy in the Treatment of Neuropathic Pain
    McMullin, Preston R.
    Hynes, Alexander Thomas
    Arefin, Mohammed Ahnaf
    Saeed, Moawiz
    Gandhavadi, Sarvani
    Arefin, Nuha
    Eckmann, Maxim S.
    CURRENT PAIN AND HEADACHE REPORTS, 2022, 26 (09) : 693 - 699
  • [38] Infusion Therapy in the Treatment of Neuropathic Pain
    Preston R. McMullin
    Alexander Thomas Hynes
    Mohammed Ahnaf Arefin
    Moawiz Saeed
    Sarvani Gandhavadi
    Nuha Arefin
    Maxim S. Eckmann
    Current Pain and Headache Reports, 2022, 26 : 693 - 699
  • [39] Oral ketamine for the treatment of neuropathic pain in humans
    Takeda, T
    Iida, H
    Oda, A
    Asano, T
    Dohi, S
    ANESTHESIOLOGY, 1996, 85 (3A) : A798 - A798
  • [40] Topical amitriptyline and ketamine for the treatment of neuropathic pain
    Mercadante, Sebastiano
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (11) : 1249 - 1253